X4 Pharmaceuticals Inc. (XFOR)
NASDAQ · Healthcare
X4 Pharmaceuticals Inc. Income Statement 2018–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | |
|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||
| Revenue | 35.1M | 2.6M | 0 | 0 | 0 | 3.0M | 0 | 0 |
| Gross Profit | — | — | — | — | — | — | — | — |
| Profitability | ||||||||
| Operating Income | -86.9M | -36.4M | -107.5M | -87.6M | -85.1M | -59.9M | -51.7M | -29.1M |
| EBITDA | — | — | — | — | — | — | — | — |
| Net Income | -79.2M | -37.5M | -101.2M | -93.9M | -88.7M | -62.1M | -52.8M | -33.3M |
| Per Share Data | ||||||||
| EPS (diluted) | — | — | — | — | — | — | — | — |
| Shares Outstanding (dil.) | 42M | 7M | 6M | 64M | 26M | 20M | 16M | 0M |
X4 Pharmaceuticals Inc. Income Statement — FAQ
X4 Pharmaceuticals Inc. (XFOR) income statement over the last 8 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see XFOR's income statement history?
The chart and table above show X4 Pharmaceuticals Inc.'s income statement by year and by quarter, including the growth rate.